I-Mab (NASDAQ:IMAB) said on Thursday that it has signed an agreement to acquire Bridge Health Biotech. As part of the deal, I-Mab will provide an initial payment of $1.8M to Bridge Health shareholders ...

Over 30 million people in Europe live with a rare disease. Most of them still lack access to accurate diagnosis or treatment ...

Brisbane-based biotech company Eclipse Ingredients has launched publicly with $7.2 million in funding after navigating a long ...

Regulatory upheaval in the US and a venture capital drought are dampening investor appetites, but there are still diamonds in ...

The self-funded medical beauty market has gradually integrated into consumers' daily life, combining the pursuit of outer aesthetics with inner self-confidence, resulting in significant growth in the ...

Prof. Ganesan Karthikeyan, Executive Director of THSTI, opened the event by emphasizing the urgent need for multidisciplinary ...

Danaher India partners with THSTI to enhance biomanufacturing, life sciences, and healthcare solutions in India, focusing on ...

In a nation with ambitions as bold as Qatar’s, healthcare is more than a service — it is a cornerstone of progress, ...

Johannes Fruehauf left Germany for the United States more than 20 years ago to propel his scientific career. But amid ...

The new space is a free community service meant to help healthcare entrepreneurs connect with potential funders.

Oscar-winning actress Lupita Nyong’o is sharing about her experience of being diagnosed with uterine fibroids, using the ...

Lumos Diagnostics signs exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of FebriDX in US.